DanCann Pharma AS (STU:DAN0) Research & Development: €0.00 Mil (TTM As of Sep. 2025)


STU:DAN0 DanCann Pharma AS STU:DAN0
27 GF Score
Price €0.00
! 3 Warning Signs
View Full Analysis

What is DanCann Pharma AS Research & Development?

DanCann Pharma AS STU:DAN0 27 Research & Development is €0.00 Mil as of Sep. 2025. GuruFocus rates STU:DAN0 with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. DanCann Pharma AS's Research & Development for the three months ended in Sep. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was €0.00 Mil.

DanCann Pharma AS  (STU:DAN0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

DanCann Pharma AS Research & Development Related Terms

DanCann Pharma AS Research & Development Historical Data

* Premium members only.

The historical data trend for DanCann Pharma AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DanCann Pharma AS Research & Development Chart

DanCann Pharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

DanCann Pharma AS Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:DAN0
27GF Score
DanCann Pharma AS STU:DAN0
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DanCann Pharma AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
DanCann Pharma AS (STU:DAN0) has a Research & Development of €0.00 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on DanCann Pharma AS and its competitors.
Is DanCann Pharma AS's Research & Development too high?
DanCann Pharma AS's current Research & Development is €0.00 Mil. Overall, DanCann Pharma AS has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does DanCann Pharma AS's Research & Development compare to ZTS and UTHR?
DanCann Pharma AS's Research & Development of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on DanCann Pharma AS and its competitors. DanCann Pharma AS's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DanCann Pharma AS stock overvalued right now?
DanCann Pharma AS (STU:DAN0) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. DanCann Pharma AS's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For DanCann Pharma AS (STU:DAN0), the current Research & Development is €0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DanCann Pharma AS Business Description

Address Rugvaenget 5, Ansager, DNK, DK-6823
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
27GF Score

Get the complete analysis for STU:DAN0

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price